Log In
Print
BCIQ
Print
Print this Print this
 

ACHN-975

  Manage Alerts
Collapse Summary General Information
Company Achaogen Inc.
DescriptionN-acetylglucosamine deacetylase (LpxC) inhibitor
Molecular Target UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (LpxC)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationBacterial infection
Indication DetailsTreat serious infections caused by multidrug-resistant Gram-negative bacteria
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today